N.O.max ER By XYMOGEN Overview & Drug Interactions
Check For Interactions With N.O.max ER
Supplement: N.O.max ER by XYMOGEN
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Arginine Alpha-Ketoglutarate
Ingredient Group | Arginine Alpha Ketoglutarate |
---|---|
Category | non-nutrient/non-botanical |
ACTINOS2 Whey Peptide Fraction
Whey protein is a type of protein derived from cow's milk. Specifically, whey comes from the cheesemaking process. Enzymes are added to milk, which separates the milk into cheese curds and liquid whey. Whey is a complete protein, meaning that it contains all nine essential amino acids that the body needs but cannot produce on its own. Whey protein is often used as a supplement to help build and repair muscle tissue, and it is popular among athletes and bodybuilders. There are three main types of whey protein: concentrate, isolate, and hydrolysate. The concentrate contains a higher amount of lactose (milk sugar) and fat, while isolate is a purer form of protein that contains less lactose and fat. Hydrolysate is a predigested form of whey protein that is easier for the body to absorb. Whey protein is often consumed in the form of powders, shakes, and bars, and it can be mixed with water, milk, or other beverages. Drug interactions with whey protein typically result due to the calcium content of whey, which can decrease absorption of some drugs, including many classes of antibiotics.
See More Information Regarding Whey ProteinIngredient Group | Whey Protein |
---|---|
Category | protein |
Drugs that interact with N.O.max ER by XYMOGEN
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
3 Caplet(s)
|
Maximum serving Sizes: |
3 Caplet(s)
|
Servings per container | 60 |
UPC/BARCODE | 871149001643 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Arginine Alpha-Ketoglutarate |
1.98 Gram(s)
|
Arginine Alpha Ketoglutarate |
--
|
ACTINOS2 Whey Peptide Fraction |
150 mg
|
Whey Protein |
--
|
Other Ingredients: |
Cellulose
Cellulose derivatives
Stearic Acid
Magnesium Stearate
Silica
Glycerin
|
---|
Label Statments:
General Statements |
- Professional use only
Not for resale on third-party websites, including, but not limited to, Amazon and eBay.
- Exclusive professional formulas
- This package is completely recyclable
|
---|---|
Suggested/Recommended/Usage/Directions |
- Directions: Take three caplets twice per day: 3 caplets 30 minutes before breakfast and 3 caplets again 30 minutes before lunch with 8 ounces of water.
|
Formula |
- N.O.max ER represents a patented, extended-release nitric oxide precursor. Scientists now refer to nitric oxide (NO) as the “foundation” of cardiovascular health. This tiny molecule is a vasodilator responsible for controlling blood flow to the entire body, which may help support healthy blood flow pressure and promote the health of the endothelium—the inside of blood vessels. With age comes diminished NO levels; that’s why since 1998, when three scientists won the Nobel Prize for their discovery of NO, researchers have been working to harness its heart-healthy activity. Today, with the application of XYMOGEN’s extended-release technology, that activity has been realized with N.O.max ER
- Extended-release arginine alpha-ketoglutarate
Clinically-tested ingredient-Issued U.S. Patents.
- Up-regulated with:
ACTINOS2
NOS-enhancing peptide fraction
|
FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Precautions |
- Consult your healthcare practitioner prior to use, especially if you have or suspect you have a medical condition, including diabetes or cold sores; if you take prescription drugs or are allergic to any ingredient; or if you are pregnant or lactating.
- Keep out of reach of children. This product is not intended for use by individuals under 18 years of age.
Storage: Keep closed in a cool, dry place out of reach of children.
- Do not use if tamper seal is damaged. The labeling on this product does not comply with California's Proposition 65. Therefore, this product may not be sold in California.
- Contains: Milk
|
Storage |
- Storage: Keep closed in a cool, dry place out of reach of children.
|
Formulation |
- Formulated to Exclude: Wheat, gluten, corn, yeast, soy, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.
|
FDA Statement of Identity |
- Dietary Supplement
|
Seals/Symbols |
- ePV (ePedigree Verification)
- GMP Compliant
Third-party verified
|
Brand IP Statement(s) |
- Protected by U.S. Patents: 6,905,707 and 7,579,020.
- Copyright 2020 XYMOGEN
- ACTINOS2 is a registered trademark of Glanbia plc.
|
Brand Information
See all products by this brand
Distributed by | |
---|---|
Name | XYMOGEN Exclusive Professional Formulas |
Street Address | 6900 Kingspointe Pkwy. |
City | Orlando |
State | FL |
ZipCode | 32819 |
Phone Number | 800-647-6100 |
Web Address | www.xymogen.com |
Researched & Developed by | |
Name | Medical Research Institute |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.